Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Neoadjuvant Radiochemotherapy in Rectal Cancer
NCT01443377Phase 2Completed
- Sponsor
- National Center for Tumor Diseases
- Start
- Jul 2011
- Primary completion
- Sep 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in rectal cancer, sponsored by National Center for Tumor Diseases. Started Jul 2011; status: completed.
02
Drugs
panitumumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01443377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01443377.